HCmed Innovations CoTPE:6934 -2.16%11 Days Payable is 19.50 as of Dec. 2025, which is 128% above its 10-year median of 8.57. GuruFocus rates TPE:6934 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, HCmed Innovations Co ranks worse than 77.48% on this metric.
The historical rank and industry rank for HCmed Innovations Co's Days Payable or its related term are showing as below:
TPE:6934'
s Days Payable Range Over the Past 10 Years
Min: 0.02 Med: 8.57 Max: 38.02
Current: 38.02
During the past 5 years, HCmed Innovations Co's highest Days Payable was 38.02. The lowest was 0.02. And the median was 8.57.
TPE:6934's Days Payable is ranked worse than 77.48% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs TPE:6934: 38.02
The historical data trend for HCmed Innovations Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6934 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, HCmed Innovations Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HCmed Innovations Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, HCmed Innovations Co's Days Payable distribution charts can be found below:
* The bar in red indicates where HCmed Innovations Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
HCmed Innovations Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HCmed Innovations Co (TPE:6934) has a Days Payable of 19.50 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on HCmed Innovations Co and its competitors. This is 128% above median its historical median of 8.57. Over the past decade, HCmed Innovations Co's Days Payable has ranged from 0.02 to 38.02. According to the industry distribution chart, HCmed Innovations Co ranks #616 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 77.5%.
Is HCmed Innovations Co's Days Payable too high?
HCmed Innovations Co's current Days Payable of 19.50 is 128% above median its 10-year median of 8.57. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 38.02. The Medical Devices & Instruments industry median Days Payable is 68.07. HCmed Innovations Co's value of 19.50 is 71.4% below this industry median. Based on the distribution chart, HCmed Innovations Co ranks #616 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, HCmed Innovations Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does HCmed Innovations Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HCmed Innovations Co ranks #616 out of 795 companies for Days Payable. This places HCmed Innovations Co in the lower half of its industry. The industry median Days Payable is 68.07. HCmed Innovations Co's value of 19.50 is 71.4% below this benchmark. Historically, HCmed Innovations Co's own Days Payable has ranged from 0.02 to 38.02 over the past decade. While the company's 10-year median is 8.57 vs. the industry median of 68.07, HCmed Innovations Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HCmed Innovations Co's current Days Payable of 19.50 is 71.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on HCmed Innovations Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HCmed Innovations Co's current Days Payable is 19.50, which is 128% above median its own 10-year median of 8.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCmed Innovations Co stock overvalued right now?
HCmed Innovations Co (TPE:6934) has a current Days Payable of 19.50. The current Days Payable is 19.50, which is 128% above median its 10-year median of 8.57 and 71.4% below the Medical Devices & Instruments industry median of 68.07. HCmed Innovations Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For HCmed Innovations Co (TPE:6934), the current Days Payable is 19.50 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HCmed Innovations Co Ltd is engaged in designing, developing, manufacturing and selling drug delivery system. It is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product includes Pulmogine. Geographically, the company operates in America, Europe, Asian and African regions.
11GF Score
Get the complete analysis for TPE:6934
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6934 has been successfully added to your 
